Literature DB >> 11420782

The effect of season and vitamin D supplementation on bone mineral density in healthy women: a double-masked crossover study.

R Patel1, D Collins, S Bullock, R Swaminathan, G M Blake, I Fogelman.   

Abstract

Vitamin D status is known to be an important determinant of bone mineral density (BMD). There is a significant seasonal variation in serum vitamin D, and some studies have reported an associated seasonal variation in BMD. The present study was devised to investigate whether a seasonal variation in BMD could be detected in healthy normal subjects, along with associated variations in serum parathyroid hormone (PTH), intestinal calcium absorption and biochemical markers of bone turnover. A second aim was to investigate whether, if such variations were identified, they could be suppressed by vitamin D supplementation. The subjects were 70 healthy female volunteers (mean age 47.2 years, range 24-70 years) recruited into a double-masked crossover study and followed over 2 years. During the first year 35 subjects received a daily oral supplement containing 800 IU (20 micrograms) cholecalciferol (group 1) and 35 subjects received a placebo preparation (group 2). During the second year the treatment each group received was reversed. Lumbar spine (L1-L4), left proximal femur and total body BMD were measured by DXA at 3-month intervals. Serum 25-hydroxyvitamin D (25-OHD), serum PTH, bone markers (bone-specific ALP (BSAP) and urinary crosslinks (DYPD/creatinine)) and calcium absorption were also measured at each visit. Cholecalciferol treatment increased serum 25-OHD by 25.4 nmol/l (p < 0.001), while a reciprocal decrease in serum PTH of 6.6 ng/l (p = 0.011) was seen in subjects in the lowest quartile of baseline serum 25-OHD. The treatment had no significant effect on spine, femur or total body BMD, calcium absorption or bone markers. When Fourier analysis was used to analyze the data for seasonal effect (defined as twice the amplitude of the 1-year period variation) a highly significant effect for 25-OHD of 18 nmol/l (p < 0.001) was found. However, no effect was found for BMD, PTH, calcium absorption or bone markers. The analysis set a 95% confidence limit to the seasonal effect of less than 0.6% for spine, total hip and total body BMD. It was concluded that in the population of healthy women studied there was no evidence of seasonal variation in spine, femur or total body BMD, serum PTH, calcium absorption or bone markers. Vitamin D supplementation was found to have no effect on BMD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420782     DOI: 10.1007/s001980170122

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  13 in total

1.  Physical performance and life quality in postmenopausal women supplemented with vitamin D: a two-year prospective study.

Authors:  Li-hong Gao; Wen-jun Zhu; Yu-juan Liu; Jie-mei Gu; Zhen-lin Zhang; Ou Wang; Xiao-ping Xing; Ling Xu
Journal:  Acta Pharmacol Sin       Date:  2015-08-17       Impact factor: 6.150

Review 2.  Bone remodeling markers: assessment of fracture risk and fracture risk reduction.

Authors:  Aubrey Blumsohn
Journal:  Curr Osteoporos Rep       Date:  2003-12       Impact factor: 5.096

3.  25-Hydroxyvitamin D level does not reflect intestinal calcium absorption: an assay using strontium as a surrogate marker.

Authors:  Marília Brasilio Rodrigues Camargo; Tatiane Vilaça; Lilian Fukusima Hayashi; Olguita G Ferreira Rocha; Marise Lazaretti-Castro
Journal:  J Bone Miner Metab       Date:  2014-05-24       Impact factor: 2.626

4.  Relationship between vitamin D, parathyroid hormone, and bone health.

Authors:  A J Sai; R W Walters; X Fang; J C Gallagher
Journal:  J Clin Endocrinol Metab       Date:  2010-12-15       Impact factor: 5.958

5.  Efficacy of optimization of vitamin D in preventing osteoporosis and osteoporotic fractures: A systematic review.

Authors:  Kazutoshi Nakamura; Masayuki Iki
Journal:  Environ Health Prev Med       Date:  2006-07       Impact factor: 3.674

6.  Vitamin D status and impact of vitamin D3 and/or calcium supplementation in a randomized pilot study in the Southeastern United States.

Authors:  Marjorie L McCullough; Roberd M Bostick; Carrie R Daniel; W Dana Flanders; Aasma Shaukat; Jill Davison; Udaya Rangaswamy; Bruce W Hollis
Journal:  J Am Coll Nutr       Date:  2009-12       Impact factor: 3.169

7.  Vitamin D insufficiency: disease or no disease?

Authors:  Karen E Hansen; Andrea N Jones; Mary J Lindstrom; Lisa A Davis; Jean A Engelke; Martin M Shafer
Journal:  J Bone Miner Res       Date:  2008-07       Impact factor: 6.741

8.  Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research.

Authors:  Michelle C Janelsins; Karen M Mustian; Luke J Peppone; Lisa K Sprod; Michelle Shayne; Supriya Mohile; Kavita Chandwani; Jennifer S Gewandter; Gary R Morrow
Journal:  J Cancer Sci Ther       Date:  2011-09-29

Review 9.  Vitamin D and bone health: potential mechanisms.

Authors:  Eamon Laird; Mary Ward; Emeir McSorley; J J Strain; Julie Wallace
Journal:  Nutrients       Date:  2010-07-05       Impact factor: 5.717

10.  Vitamin D dose response is underestimated by Endocrine Society's Clinical Practice Guideline.

Authors:  Malachi J McKenna; Barbara F Murray
Journal:  Endocr Connect       Date:  2013-04-12       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.